IVF and retinoblastoma revisited

Testing of retinoblastoma tumors provides no proof for epigenetic hypermethylation of the RB1 promoter in retinoblastoma tumors of children conceived by IVF or ICSI.
Like

Authors

Charlotte J. Dommering, M.D., Annemarie H. van der Hout, Ph.D., Hanne Meijers-Heijboer, M.D., Ph.D., Tamara Marees, Ph.D., Annette C. Moll, M.D., Ph.D.

Volume 97, Issue 1 , Pages 79-81

Abstract

Objective:

To evaluate the suggested association between IVF, retinoblastoma, and tumor methylation characteristics.

Design:

Laboratory analysis.

Setting:

National Retinoblastoma Center in the Netherlands.

Patient(s):

Retinoblastoma tumors from seven children conceived by IVF or intracytoplasmic sperm injection (ICSI).

Intervention(s) and Main Outcome Measure(s):

DNA from frozen retinoblastoma tumors was tested for mutations in the RB1 gene and for methylation status of the RB1 promoter.

Result(s):

For all tumors two causative RB1 mutations were found. None of the tumors showed hypermethylation of the RB1 promoter.

Conclusion(s):

Examination of retinoblastoma tumors of seven children conceived by IVF or ICSI did not show hypermethylation of the RB1 promoter. This demonstrates that an association between IVF or ICSI and retinoblastoma through this epigenetic mechanism is unlikely.

Read the full text at: http://www.fertstert.org/article/S0015-0282(11)02720-8/fulltext

Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.